DCT
1:22-cv-00294
Novo Nordisk Inc v. Rio Biopharma Inc
General
Filed
03/04/22
Cause of ActionPatent Infringement
SectorMech Eng, Manuf
Status
Closed (09/11/24)
Patent Owner
NPEÂ (L)
PACER
1:22-cv-00294
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
03/09/22 - 12/13/24 | 44% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L1 E | |
L4 A | |
L4 A | |
L2 A | |
L2 B | |
L1 B | |
L1 B | |
L1 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
-- -- -- | |
L5 E | |
L4 E | |
L4 E | |
L4 E | |
L2 D | |
-- -- -- | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 B | |
L4 E | |
L2 C | |
L2 E | |
-- -- -- | |
-- -- -- | |
L5 C | |
L5 E | |
L2 B | |
Shaw Keller LLPLocal | L5 D |
L5 B | |
L5 E | |
L3 A | |
L5 E | |
L5 B | |
L2 D | |
L4 B | |
L4 C | |
L4 D | |
L4 E | |
L1 C | |
-- -- -- | |
Morris James LLPLocal | L4 E |
L5 E | |
L3 A | |
L3 C | |
L2 E | |
-- -- -- | |
L3 E | |
L5 E | |
L4 E | |
L1 C | |
-- -- -- | |
-- -- -- | |
L3 E | |
L4 E | |
L4 E | |
L2 D | |
L2 E | |
L3 E | |
L5 E |
No Attorneys